Completed
Dual Thrombolytic Therapy With Mutant Pro-urokinase and Low Dose Alteplase for Ischemic Stroke
NCT04256473
- Conditions
- Brain Diseases, Cardiovascular Diseases, Central Nervous System Diseases, +9 more
- Locations
-
- DUMAS trial office Rotterdam, Netherlands